Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2014

Segment information is as follows (in thousands):



Balance Sheet Data:	As of June 30, 2014
	Ligand			CyDex		Total
Total assets	$	32,577		$	67,270	$	99,847

	As of December 31, 2013
	Ligand			CyDex		Total
Total assets	$	38,408		$	66,305	$	104,713

Operating Data:	For the three months ended June 30, 2014
	Ligand			CyDex		Total
Net revenues from external customers	$	5,692		$	4,916	$	10,608
Depreciation and amortization expense	68			601		669
Operating (loss) income	(867		)	2,225		1,358
Interest expense, net	181			—		181
Income tax expense from continuing operations	45			2		47

	For the three months ended June 30, 2013
	Ligand			CyDex		Total
Net revenues from external customers	3,820			5,760		$	9,580
Depreciation and amortization expense	59			610		$	669
Write-off of in-process research and development	—			480		$	480
Operating (loss) income	(1,200		)	2,714		$	1,514
Interest expense, net	453			—		$	453
Income tax expense (benefit) from continuing operations	(145		)	35		$	(110	)
Gain on sale of Avinza Product Line before income taxes	2,397			—		$	2,397

	For the six months ended June 30, 2014
	Ligand			CyDex		Total
Net revenues from external customers	12,483			$	14,083	$	26,566
Depreciation and amortization expense	134			1,203		1,337
Operating (loss) income	(938		)	7,396		6,458
Interest expense, net	429			—		429
Income tax expense from continuing operations	6			—		6

	For the six months ended June 30, 2013
	Ligand			CyDex		Total
Net revenues from external customers	$	10,057		$	11,174	$	21,231
Depreciation and amortization expense	117			1,222		1,339
Write-off of in-process research and development	—			480		480
Operating income	198			5,249		5,447
Interest expense, net	1,361			—		1,361
Income tax expense (benefit) from continuing operations	(205		)	29		(176		)
Gain on sale of Avinza Product Line before income taxes	2,588			—		2,588

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details